These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7141199)

  • 1. Plasma pancreatic glucagon in pancreatic and primary diabetes, and liver cirrhosis: application of a correction to the radioimmunoassay for pancreatic glucagon.
    Okumura N; Hayakawa T; Yasui K; Noda A; Kondo T; Otsuka K; Nimura Y
    Gastroenterol Jpn; 1982; 17(4):347-52. PubMed ID: 7141199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancy of fasting plasma glucagon levels measured by different glucagon antisera.
    Tahara Y; Tanaka A; Yamamoto Y; Fukuda M; Kumahara Y; Shima K
    Diabetes Res; 1988 Apr; 7(4):179-83. PubMed ID: 3402167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of a "big plasma glucagon" response during arginine stimulation of glucagon secretion.
    von Schenck H; Vasquez B; Unger RH
    Horm Metab Res; 1982 Feb; 14(2):69-71. PubMed ID: 7068099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
    Kawakami K
    Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):155-70. PubMed ID: 3294051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans. Paradoxical response to oral glucose.
    Bajorunas DR; Fortner JG; Jaspan JB
    Diabetes; 1986 Aug; 35(8):886-93. PubMed ID: 3525286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a sensitive and specific radioimmunoassay for pancreatic glucagon in human plasma and its clinical application.
    Borghi VC; Wajchenberg BL; Albuquerque RH
    Clin Chim Acta; 1984 Jan; 136(1):39-48. PubMed ID: 6692564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians.
    Aronoff SL; Bennett PH; Unger RH
    J Clin Endocrinol Metab; 1977 May; 44(5):968-72. PubMed ID: 870519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High molecular weight glucagon-like immunoreactivity in plasma.
    Weir GC; Knowlton SD; Martin DB
    J Clin Endocrinol Metab; 1975 Feb; 40(2):296-302. PubMed ID: 1117980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.
    Kuku SF; Zeidler A; Emmanouel DS; Katz AI; Rubenstein AH
    J Clin Endocrinol Metab; 1976 Jan; 42(1):173-6. PubMed ID: 1249185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Big plasma glucagon in patients with liver cirrhosis. The discrepancy in values of immunoreactive glucagon measured by use of two different antisera against pancreatic glucagon, 30K and OAL-123].
    Tsubouchi H; Kamibeppu A; Fujisaki K; Oka H; Miyazaki H; Hirono S; Hashimoto S; Nagahama J; Gohda E; Daikuhara Y
    Nihon Shokakibyo Gakkai Zasshi; 1984 May; 81(5):1208-13. PubMed ID: 6471533
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of pancreatic alpha cell function in normal and diabetic subjects.
    Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
    J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis.
    Del Prato S; Riva F; Devidé A; Nosadini R; Fedele D; Tiengo A
    Acta Diabetol Lat; 1980; 17(2):111-8. PubMed ID: 7004039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exaggerated glucagon secretion in diabetic and non-diabetic subjects with surgical porto-caval anastomosis.
    Fallucca F; Ziparo V; Giangrande L; Menzinger G; Stipa S
    Horm Metab Res; 1981 Oct; 13(10):545-7. PubMed ID: 7298009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of islet alpha cell function in pancreatectomized patients.
    Tiengo A; Bessioud M; Valverde I; Tabbi-Anneni A; Delprato S; Alexandre J; Assan R
    Diabetologia; 1982 Jan; 22(1):25-32. PubMed ID: 6120875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the liver in glucagon metabolism.
    Jaspan JB; Huen AH; Morley CG; Moossa AR; Rubenstein AH
    J Clin Invest; 1977 Aug; 60(2):421-8. PubMed ID: 874100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.